Aclaris Therapeutics (ACRS) Intangibles (2017 - 2023)
Aclaris Therapeutics' Intangibles was $269,000 in Q4 2023, down 96.1% from $6.97 million a year earlier and down 96.1% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Intangibles (2017 - 2023) Analysis & Trends
From Q3 2017 onward, Aclaris Therapeutics has reported Intangibles for 26 quarters.
- Intangibles has now declined for six consecutive years, with a five-year compound annual growth rate of -48.3% (FY2018 to FY2023).
- In earlier years, Intangibles was $6.97 million in FY2022 (-1.1%), $7.05 million in FY2021 (-1.1%), $7.12 million in FY2020 (-1.1%) and $7.2 million in FY2019 (-1.0%).
- The Q4 2023 figure marks the lowest quarterly Intangibles in data going back to Q3 2017.
- Compared with a year earlier, Intangibles has declined for 18 straight quarters, with an average decline of 13.0% over the last eight quarters.
- The best year-over-year quarter for Intangibles over five years was Q1 2019 (growth of 874.9%); the worst was Q4 2023 (a decline of 96.1%).
- Per Business Quant data, ACRS's Intangibles in the three quarters before Q4 2023 was $6.92 million (Q3 2023), $6.94 million (Q2 2023) and $6.95 million (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Aclaris Therapeutics | 735.48 Mn | 735.48 Mn | 1.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 269,000.00 |
| Sep 30, 2023 | 6.92 Mn |
| Jun 30, 2023 | 6.94 Mn |
| Mar 31, 2023 | 6.95 Mn |
| Dec 31, 2022 | 6.97 Mn |
| Sep 30, 2022 | 6.99 Mn |
| Jun 30, 2022 | 7.01 Mn |
| Mar 31, 2022 | 7.03 Mn |
| Dec 31, 2021 | 7.05 Mn |
| Sep 30, 2021 | 7.07 Mn |
| Jun 30, 2021 | 7.09 Mn |
| Mar 31, 2021 | 7.11 Mn |
| Dec 31, 2020 | 7.12 Mn |
| Sep 30, 2020 | 7.14 Mn |
| Jun 30, 2020 | 7.16 Mn |
| Mar 31, 2020 | 7.18 Mn |
| Dec 31, 2019 | 7.20 Mn |
| Sep 30, 2019 | 7.22 Mn |
| Jun 30, 2019 | 69.78 Mn |
| Mar 31, 2019 | 71.46 Mn |
API Access
Aclaris Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();